Concepedia

Matthew F. Wipperman

MF

19

Publications

1.4K

Citations

15

H-Index

2013

Active since

Affiliations

Regeneron (United States)(Current)

Cornell University

Weill Cornell Medicine

Memorial Sloan Kettering Cancer Center

Gheskio Centers

Matthew F. Wipperman is an author at Regeneron (United States) specializing in medicine, microbiology, and immunology.

ORCID

Top concepts

Publications per year

2013–2024

19

Publications

19

Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis

Evan S. Dellon, Marc E. Rothenberg, Margaret H. Collins et al. · New England Journal of Medicine · 2022 · 413 citations

Antibiotic treatment for Tuberculosis induces a profound dysbiosis of the microbiome that persists long after therapy is completed

Matthew F. Wipperman, Daniel W. Fitzgerald, Marc Antoine Jean Juste et al. · Scientific Reports · 2017 · 194 citations · Full text

Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy

Sivaranjani Namasivayam, Mamoudou Maïga, Wuxing Yuan et al. · Microbiome · 2017 · 145 citations · Full text

Shrinking the FadE Proteome of Mycobacterium tuberculosis: Insights into Cholesterol Metabolism through Identification of an α <sub>2</sub> β <sub>2</sub> Heterotetrameric Acyl Coenzyme A Dehydrogenase Family

Matthew F. Wipperman, Meng Yang, Suzanne T. Thomas et al. · Journal of Bacteriology · 2013 · 90 citations · Full text

Dupilumab for Eosinophilic Esophagitis in Patients 1 to 11 Years of Age

Mirna Chehade, Evan S. Dellon, Jonathan M. Spergel et al. · New England Journal of Medicine · 2024 · 83 citations

Rows per page

1–5 of 19